A304840 Stock Overview
A biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
PeopleBio, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,530.00 |
| 52 Week High | ₩6,090.00 |
| 52 Week Low | ₩2,590.00 |
| Beta | 0.57 |
| 11 Month Change | -4.59% |
| 3 Month Change | -8.55% |
| 1 Year Change | -1.81% |
| 33 Year Change | -72.58% |
| 5 Year Change | n/a |
| Change since IPO | -63.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| A304840 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -4.1% | -4.5% | 2.4% |
| 1Y | -1.8% | 21.1% | -4.0% |
Return vs Industry: A304840 underperformed the KR Biotechs industry which returned 21.1% over the past year.
Return vs Market: A304840 exceeded the KR Market which returned -4% over the past year.
Price Volatility
| A304840 volatility | |
|---|---|
| A304840 Average Weekly Movement | 11.4% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A304840's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A304840's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 65 | Sungmin Kang | www.peoplebio.net |
PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.
PeopleBio, Inc. Fundamentals Summary
| A304840 fundamental statistics | |
|---|---|
| Market cap | ₩74.24b |
| Earnings (TTM) | -₩13.21b |
| Revenue (TTM) | ₩4.46b |
16.6x
P/S Ratio-5.6x
P/E RatioIs A304840 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A304840 income statement (TTM) | |
|---|---|
| Revenue | ₩4.46b |
| Cost of Revenue | ₩3.04b |
| Gross Profit | ₩1.42b |
| Other Expenses | ₩14.63b |
| Earnings | -₩13.21b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -628.04 |
| Gross Margin | 31.92% |
| Net Profit Margin | -296.21% |
| Debt/Equity Ratio | 5.2% |
How did A304840 perform over the long term?
See historical performance and comparison